Brief: Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results

Fusion Pharmaceuticals

16/03/2023 11:46

March 16 (Reuters) - Fusion Pharmaceuticals Inc
 FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES FOURTH QUARTER 2022
FINANCIAL
RESULTS AND CLINICAL PROGRAM UPDATES
    * FUSION PHARMACEUTICALS INC - FPI-1434 PRELIMINARY PHASE 1
DATA
EXPECTED IN Q2 2023
    * FUSION PHARMACEUTICALS INC - FPI-1966 AND FPI-2059 PHASE 1
TRIALS OPEN AND RECRUITING PATIENTS
    * FUSION PHARMACEUTICALS INC - STRONG BALANCE SHEET WITH
RUNWAY
INTO Q1 2025 SUPPORTS ONGOING EXECUTION OF MULTIPLE CLINICAL
PROGRAMS
    * FUSION PHARMACEUTICALS INC - AS OF DECEMBER 31, 2022,
FUSION
HELD CASH, CASH EQUIVALENTS AND INVESTMENTS OF $186.6 MILLION
    * FUSION PHARMACEUTICALS INC- QTRLY LOSS PER SHARE $0.55

Source text for Eikon:  ID:nPn6bFqJGa 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))